Human promyelocytic leukaemia (HL-60) cells were employed to study the induction of NAD+-dependent 15 mediated by protein kinase C activation, since an inactive analogue of PMA failed to induce the effect, and both staurosporine and H-7 blocked the stimulation. Stimulation by PMA was optimal at 10 nm and less effective at higher concentrations. Western blot studies indicated that a similar, if not greater, amount of enzyme protein was induced at high concentrations of PMA, suggesting that enzyme inactivation might be occurring. Possible enzyme inactivation by protein kinase C activation was further examined by incubating DMSO-treated cells with a high concentration of PMA (50 nM). Time-dependent inactivation of 15-PGDH within the first 1 h was observed and this inactivation was partially blocked by staurosporine and H-7. Pulse-chase experiments indicated that 15-PGDH had a rapid turnover rate (t = 47 min), and PMA shortened the half-life of the enzyme (ti = 33 min), suggesting that PMA might have an additional effect on 15-PGDH degradation. The rapid turnover of 15-PGDH indicates that the enzyme activity depends on continued enzyme synthesis, and this could be susceptible to hormone and drug control mechanisms.
INTRODUCTION
NAD+-dependent 1 5 -hydroxyprostaglandin dehydrogenase (15-PGDH, EC 1.1.1.141) catalyses oxidation of the 15(S) hydroxyl group of prostaglandins to the 1 5-oxo function, resulting in a substantial decrease in the biological activities of prostaglandins [1] . This enzyme has been considered to be the key enzyme in controlling the biological inactivation of prostaglandins. Several pharmacological agents, including thyroid hormones [2] , non-steroidal anti-inflammatory drugs [3, 4] , antiallergic drugs [5] , acrolein [6] and anti-psychotic drugs [7] have been shown to inhibit or stimulate the enzyme directly. Some physiological and pathological conditions such as pregnancy [8] , ontogenic development [9] , hormone [10] and steroid [11] administration are also known to alter the enzyme activity although the mechanism of enzyme regulation remains to be elucidated.
Although the enzyme is ubiquitously present in mammalian tissues [12] , the specific cell types responsible for prostaglandin catabolism are not clear. It would be desirable if a specific cell type could be identified and cultured to facilitate studies on the regulation of 1 5-PGDH. We have found that human promyelocytic leukaemia (HL-60) cells can be induced by phorbol esters to exhibit 15-PGDH activity. In the present investigation we focused attention on the induction and regulation of 15- PGDH by phorbol 12-myristate 13-acetate (PMA) in this HL-60 model system. A preliminary report of this study has been presented in an abstract form [13] . EXPERIMENTAL 
Materials
PMA, 4a-phorbol 12,13-didecanoate (PDD), dimethyl sulphoxide (DMSO), penicillin, streptomycin, RPMI 1640, NADI, 2-oxoglutarate, dithiothreitol (DTT), 5-bromo-4-chloro-3-indolyl phosphate, Nitro Blue tetrazoleum, bovine liver glutamate dehydrogenase (40 units/mg), actinomycin D, cycloheximide, phenylmethanesulphonyl fluoride, Tween 20 , Triton X-100, BSA, H-7 and biotinylated protein standards were obtained from Sigma Chemical Co. Biotinylated rabbit anti-mouse IgG and alkaline phosphatase-labelled streptavidin were Proteins were fractionated by SDS/PAGE according to the method of Laemmli [17] . Electrophoretic transfer of proteins from the polyacrylamide gel to nitrocellulose paper was performed according to the method of Towbin et al. [18] . Nonisotopic visualization of antigenic protein using biotinylated rabbit anti-mouse IgG and streptavidin-alkaline phosphatase was carried out according to Knecht & Dimond [19] .
135SlMethionine metabolic labelling of HL-60 cells and immunoprecipitation of 15-PGDH HL-60 cells (5 x 105/ml) were incubated in the presence or the absence of 10 nM-PMA for 16 h. The methionine-containing medium was then removed and replaced by methionine-free medium, followed by the addition of 5 ,uCi of L-[35S]methionine/ml and incubation for 4 h. The 35S-labelled medium was removed and the cells (1 x 107) were washed twice with 0.9 % NaCl and lysed with lysing buffer (0.01 M-phosphatebuffered saline containing 0.1 % Triton X-100, 1 mM-phenylmethanesulphonyl fluoride and 0.01 % EDTA). After centrifugation at 10000 g for 5 min the supernatant was incubated for 2 h with 2 ,ug of monoclonal antibody against human placental 15-PGDH, followed by the addition of 20 ,ul of a 10 % (w/v) S. aureus cell suspension and incubation for 1 h. The mixture was briefly centrifuged (2000 g, O min) and the pellet was disrupted by heating in the sample buffer before analysis by SDS/PAGE. 35S-labelled 1 After washing the wells with washing buffer, each well was broken away from the strip and the radioactivity was determined by liquid scintillation counting.
RESULTS
PMA stimulated PGE2 metabolism in HL-60 cells (Fig. 1 [16] . The effects of the concentrations of PMA and PDD on stimulation of 1 5-PGDH activity are shown in Fig. 2(a) . Maximal stimulation of 15-PGDH activity by PMA was observed at 10 nM; higher concentrations of PMA appeared to be less effective. PDD, an inactive phorbol ester, was found to be unable to stimulate 15-PGDH activity at the concentrations tested. The kinetics of stimulation of 15-PGDH activity by two different concentrations of PMA showed a biphasic profile (Fig. 2b) . Initial maximal activity was observed at 24 h after the addition of PMA. A decrease in activity was found at 36 h, followed by a ' rebound' of activity at 48 h. The biphasic nature of the increased activity induced by PMA has been reproducibly observed. Stimulation of 15-PGDH activity by PMA was found to be blocked by the addition of the protein kinase C inhibitors staurosporine and H-7 [20, 21] . Fig. 3 shows the effects of increasing concentrations of staurosporine or H-7 on PMAinduced stimulation of 1 5-PGDH activity. Almost total inhibition by staurosporine was observed at 20 nm, whereas about 60 % inhibition by H-7 was seen at 200 /LM. In addition to PMA, DMSO was also shown to stimulate 15-PGDH activity, albeit requiring a longer exposure time (Fig. 4) . Stimulation of 15-PGDH activity by DMSO was found to be significantly inhibited by staurosporine at 10 nm or H-7 at 50 /uM (Fig. 4) . Although H-7 at 200/,M was clearly more effective, it is possible that this is due to more non-specific effects. Therefore H-7 was used at 50,M. (Fig. 5 ). Cells treated with PMA for 24 h exhibited enhanced 28 The effect of PMA on methionine incorporation into newly synthesized 1 (Fig. 8) . Estimation from these slopes gave half-lives of labelled enzyme of 33 min and 47 min in the presence and absence respectively of PMA.
Human promyelocytic leukaemia (HL-60) cells have been shown to exhibit prostaglandin and thromboxane biosynthetic activity following exposure to phorbol ester [22] , lae,25-dihydroxyvitamin D3 [23] , retinoic acid [23] and DMSO [24] . [29] . DMSO, which has been shown to induce protein kinase C in HL-60 cells [30, 31] , stimulated 15-PGDH activity, and this stimulation was again blocked by staurosporine or H-7. The induction of 15-PGDH by DMSO is very likely to be mediated by DMSO-induced protein kinase C activation. 15-PGDH appears to be the second enzyme that is regulated by protein kinase C [22, 32] in the eicosanoid metabolic pathway, the first being cyclo-oxygenase. [33] . In order to provide evidence for regulation by protein kinase C-mediated phosphorylation, 15-PGDH was induced by DMSO and the cells were then subjected to treatment with 50 nM-PMA in the absence and the presence of protein kinase C inhibitors such as staurosporine and H-7. Indeed, PMA caused a time-dependent inactivation of the enzyme during the 2 h treatment. Concentrations of PMA lower than 50 nm also induced inactivation of the enzyme, although the time required to reach 50 % inactivation was longer. For rapid demonstration of a PMA effect, a concentration of 50 nm was used. Inactivation was significantly blocked by the presence of staurosporine or H-7, suggesting that inactivation of the enzyme is mediated by the activation of protein kinase C. However, definitive proof of enzyme inactivation by protein kinase C-mediated phosphorylation requires a purified enzyme preparation in order to demonstrate its inactivation by phosphorylation. Blackwell et al. [34] reported that rat kidney and lung pretreated with cycloheximide rapidly lost their ability to metabolize prostaglandins. These workers estimated the half-life of 15-PGDH to be 45-75 min. By directly measuring the disappearance of L-[35S]methionine-labelled 1 5-PGDH we found that the PMAinduced enzyme in HL-60 cells incubated with medium alone undergoes rapid degradation, with a half-life of approx. 47 min. Addition of PMA during the chase period shortens the half-life to 33 min, suggesting that PMA might have an additional effect on 15-PGDH degradation. The kinetics of degradation shows first-order kinetics, which is different from the case with the turnover of cyclo-oxygenase [31] . In view of the rapid turnover of 15-PGDH, enzyme activity will depend on continued enzyme synthesis, and this could be very susceptible to hormonal and drug control mechanisms. Several reports have demonstrated alterations in 1 5-PGDH activity caused by hormonal changes [8] , steroid administration [11] , endotoxin shock [35] or cigarette smoking [36] and in tissues from spontaneously hypertensive rats [37] . Although alteration of these enzyme activities may be the consequence of post-translational modifications of 15-PGDH, such as the phosphorylation suggested above, changes in enzyme synthesis and content are also very likely possibilities. Recently a full-length cDNA for human placental 15 -PGDH has been cloned and sequenced [38] . The availability of this cDNA should make it possible to differentiate between the above possibilities and will facilitate studies on the regulation of this important eicosanoid metabolic enzyme.
This work was supported in part by grant HL-32727 from the U.S. Public Health Services.
